3-187236125-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_139125.4(MASP1):c.1746G>A(p.Pro582Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00712 in 1,613,866 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0051 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0073 ( 65 hom. )
Consequence
MASP1
NM_139125.4 synonymous
NM_139125.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.20
Publications
6 publications found
Genes affected
MASP1 (HGNC:6901): (MBL associated serine protease 1) This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
MASP1 Gene-Disease associations (from GenCC):
- 3MC syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- 3MC syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-187236125-C-T is Benign according to our data. Variant chr3-187236125-C-T is described in ClinVar as Benign. ClinVar VariationId is 285006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.2 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00513 (781/152306) while in subpopulation SAS AF = 0.0197 (95/4824). AF 95% confidence interval is 0.0165. There are 1 homozygotes in GnomAd4. There are 403 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 65 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MASP1 | NM_139125.4 | c.1746G>A | p.Pro582Pro | synonymous_variant | Exon 11 of 11 | ENST00000296280.11 | NP_624302.1 | |
| MASP1 | NM_001879.6 | c.1303+5356G>A | intron_variant | Intron 10 of 15 | ENST00000337774.10 | NP_001870.3 | ||
| MASP1 | NR_033519.2 | n.1619G>A | non_coding_transcript_exon_variant | Exon 10 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MASP1 | ENST00000296280.11 | c.1746G>A | p.Pro582Pro | synonymous_variant | Exon 11 of 11 | 1 | NM_139125.4 | ENSP00000296280.7 | ||
| MASP1 | ENST00000337774.10 | c.1303+5356G>A | intron_variant | Intron 10 of 15 | 1 | NM_001879.6 | ENSP00000336792.5 |
Frequencies
GnomAD3 genomes AF: 0.00514 AC: 782AN: 152188Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
782
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00673 AC: 1683AN: 250114 AF XY: 0.00728 show subpopulations
GnomAD2 exomes
AF:
AC:
1683
AN:
250114
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00733 AC: 10716AN: 1461560Hom.: 65 Cov.: 80 AF XY: 0.00761 AC XY: 5532AN XY: 727116 show subpopulations
GnomAD4 exome
AF:
AC:
10716
AN:
1461560
Hom.:
Cov.:
80
AF XY:
AC XY:
5532
AN XY:
727116
show subpopulations
African (AFR)
AF:
AC:
60
AN:
33478
American (AMR)
AF:
AC:
140
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
123
AN:
26136
East Asian (EAS)
AF:
AC:
680
AN:
39700
South Asian (SAS)
AF:
AC:
1745
AN:
86256
European-Finnish (FIN)
AF:
AC:
59
AN:
53108
Middle Eastern (MID)
AF:
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
7507
AN:
1111998
Other (OTH)
AF:
AC:
394
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
803
1606
2410
3213
4016
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00513 AC: 781AN: 152306Hom.: 1 Cov.: 33 AF XY: 0.00541 AC XY: 403AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
781
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
403
AN XY:
74474
show subpopulations
African (AFR)
AF:
AC:
76
AN:
41556
American (AMR)
AF:
AC:
60
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
23
AN:
3472
East Asian (EAS)
AF:
AC:
57
AN:
5182
South Asian (SAS)
AF:
AC:
95
AN:
4824
European-Finnish (FIN)
AF:
AC:
6
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
448
AN:
68032
Other (OTH)
AF:
AC:
16
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
37
74
112
149
186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
57
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Nov 25, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
3MC syndrome 1 Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.